---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-034778"
form_type: "8-K"
ticker: "ACOG"
cik: "0001655923"
company_name: "Alpha Cognition Inc."
filed_at: "2026-03-26T23:59:59+00:00"
generated_at: "2026-05-15T08:50:43.354510+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Alpha Cognition FY2025 revenue $10.2M, net loss $20.7M; ZUNVEYL bottles up 62% QoQ

## Summary
- FY2025 total revenue $10.2M: ZUNVEYL net product revenue $6.8M + licensing $3.4M.
- Q4 ZUNVEYL net product revenue $2.5M; 4,941 bottles dispensed (+62% QoQ); December strongest month.
- Net loss $20.7M vs $14.8M in 2024; operating loss $22.7M vs $12.0M in 2024.
- Cash $66.0M at year-end; expects ~2-year runway after $40M capital raise in Oct 2025.
- Executed second national PBM contract, now covering two of four major long-term care PBMs.

## SEC filing metadata
- accession: 0001213900-26-034778
- form_type: 8-K
- ticker: ACOG
- cik: 0001655923
- company_name: Alpha Cognition Inc.
- filed_at: 2026-03-26T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1655923/000121390026034778/0001213900-26-034778-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1655923/000121390026034778/ea0283622-8k_alpha.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-034778
- JSON: https://secwatch.observer/filing/0001213900-26-034778.json
- Plain text: https://secwatch.observer/filing/0001213900-26-034778.txt

## Key facts
- Earnings Releases
  Alpha Cognition Inc. reported the year ended December 31, 2025 results: revenue $10.2 million, net income $20.7 million.
  - Period: the year ended December 31, 2025
  - Revenue: $10.2 million
  - Net income: $20.7 million
  - Result: reported results
  source text: Full Year Fiscal 2025 Financial Results ● Revenues: ZUNVEYL net product revenues were $6.8 million, and licensing revenue totaled $3.4 million, for a combined total of $10.2 million for the year ended December 31, 2025. ● Research & Development: Expenses were $1.9 million, compared to $3.9 million for fiscal year 2024 as the Company transitioned to commercial stage. ● Selling, General & Administrative : Expenses were $29.1 million, up from $8.0 million in 2024, reflecting increased commercial investment in personnel and infrastructure. ● Operating Loss: $22.7 million, compared to $12.0 million in 2024. ● Net Loss: $20.7 million, compared to $14.8 million in 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1655923/000121390026034778/0001213900-26-034778-index.htm
- Earnings Releases
  Alpha Cognition Inc. reported the fourth quarter ended December 31, 2025 results: revenue $2.5 million.
  - Period: the fourth quarter ended December 31, 2025
  - Revenue: $2.5 million
  - Result: reported results
  source text: Net ZUNVEYL Revenue: Generated approximately $2.5 million in net product revenue in the fourth quarter of 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1655923/000121390026034778/0001213900-26-034778-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.